In addition, TBX4 mutation can lead to childhood onset pulmonary arterial hypertension (PAH) with common clinical features including pulmonary capillary dysplasia, acinar dysplasia, respiratory failure, and in severe cases, death [9]. Here, TBX4 is linked to pulmonary arterial hypertension.